Latest News | Intrinsic Imaging

Intrinsic Imaging Publishes Results of Artificial Intelligence (AI) Pivotal Study in the American Journal of Roentgenology

Posted: June 21, 2018

ISO Certified Intrinsic Imaging Core Lab Completes Very Large 12,480 Read Pivotal Oncology Clinical Trial in 5 Weeks

Posted: March 20, 2018

Leading Artificial Intelligence (AI) Company Selects Intrinsic Imaging to Conduct Pivotal Clinical Trial to Support FDA Submission

Posted: January 11, 2018

Intrinsic Imaging Selected by an Emerging Artificial Intelligence (AI) Company for Pivotal Medical Device Clinical Trial

Posted: October 18, 2017

Intrinsic Imaging Awarded Pivotal Phase II Clinical Trial Focused on Treatment of Degenerative Neuromuscular Disorder

Posted: September 12, 2017

Intrinsic Imaging Awarded Tenth Clinical Trial for Computer Aided Detection (CAD) / Artificial Intelligence (AI) / Deep Learning (DL) Software

Posted: August 14, 2017

Intrinsic Imaging Awarded New Clinical Study to Evaluate Innovative Tumor Imaging Platform

Posted: July 6, 2017

Intrinsic Imaging Awarded a Validation Study for the Development of an Innovative Medical Device to Aid in the Evaluation of Gastrointestinal Motility

Posted: June 27, 2017

Intrinsic Imaging Awarded Another Pivotal Multiple-Reader Multiple-Case (MRMC) Study to Assess the Clinical Performance of CAD Software

Posted: May 17, 2017

Intrinsic Imaging Awarded GIST Clinical Trial for the Treatment of Gastrointestinal Stromal Tumors

Posted: April 4, 2017

Intrinsic Imaging Awarded Phase III Clinical Trial Focused on Brain Metastases of Non-Small Cell Lung Cancer (NSCLC)

Posted: March 29, 2017

Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Posted: March 22, 2017

Intrinsic Imaging Appoints Industry Veteran James Warpula Vice President, Quality Assurance and Compliance

Posted: March 13, 2017

Intrinsic Imaging’s Quality Management System Attains ISO 27001 Informational Security Certification

Posted: March 9, 2017

Vol. 6, Issue 10 : Inferior Vena Cava Filters

Posted: October 8, 2016

Vol. 6, Issue 9 : WHO, RECIST, mRECIST, Cheson, EASL and Novel Biologics

Posted: September 9, 2016

Intrinsic Imaging Appoints Bryan Wayne as Vice President, Imaging Operations

Posted: September 7, 2016

Vol. 6, Issue 8 : Metastatic Colorectal Cancer

Posted: August 11, 2016

Intrinsic Imaging Awarded International Clinical Trial to Determine Efficacy of Innovative Class III Medical Device

Posted: July 27, 2016

Intrinsic Imaging Awarded Large Pivotal Phase III Oncology Trial for Metastatic Breast Cancer

Posted: July 13, 2016

Vol. 6, Issue 7 : Neurological Imaging: Contrast Enhancement in Clinical Trials

Posted: July 7, 2016

Vol. 6, Issue 6 : Tissue Iron Deposition : MRI Quantitation in Clinical Trials

Posted: June 6, 2016

Vol. 6, Issue 5 : Imaging of Rheumatoid Arthritis

Posted: May 5, 2016

Intrinsic Imaging Awarded International Phase II Trial for Arthritis

Posted: May 2, 2016

Vol. 6, Issue 4 : Complex Spinal Deformities: Medical Imaging in Clinical Trials

Posted: April 4, 2016

Clinical Trial Sponsors Agree Intrinsic Imaging Core Lab Provides Exceptional Quality

Posted: March 17, 2016

Vol. 6, Issue 3 : Imaging and Monitoring Tumor Response in Clinical Trials

Posted: March 3, 2016

Intrinsic Imaging’s ISO Certified QMS to be featured at the Imaging in Clinical Trials Event

Posted: February 1, 2016

Intrinsic Imaging Awarded Pivotal Phase III Trial to Assess Novel Oral Chemotherapeutic for Metastatic Breast Cancer

Posted: October 5, 2015

Vol. 5, Issue 9 : Medical Imaging of Osteoarthritis

Posted: September 9, 2015

Vol. 5, Issue 8 : The Challenge of Quantitative Measurements of Primary Brain Tumors

Posted: August 8, 2015

Vol. 5, Issue 11 : Quantitative MRI and Imaging Endpoints in Orthopedic Clinical Trials

Posted: May 11, 2015

Vol. 5, Issue 10 : Chronic Lymphocytic Leukemia

Posted: May 10, 2015

Vol. 5, Issue 7 : Coronary Artery Calcium Scoring

Posted: May 7, 2015

Vol. 5, Issue 6 : Contrast Echocardiographic Imaging in Clinical Trials

Posted: May 6, 2015

Vol. 5, Issue 5 : irRECIST and Immuno-Oncology

Posted: May 5, 2015

Vol. 5, Issue 4 : Temporal Lobe Epilepsy and Volumetric MRI in Clinical Trials

Posted: May 4, 2015

Vol. 5, Issue 3 : Functional Imaging of the Dopamine Pathway

Posted: May 3, 2015

Vol. 5, Issue 2 : Advances in Imaging of Non-Small Cell Lung Cancer (NSCLC)

Posted: May 2, 2015

Vol. 5, Issue 1 : ImmunoTherapy and Imaging of Metastatic Pancreatic Adenocarcinoma

Posted: May 1, 2015

Intrinsic Imaging Awarded Medical Device Trial for Percutaneous Tumor Ablation

Posted: April 23, 2015

Intrinsic Imaging Awarded Phase II Clinical Trial for Glioblastoma Multiforme (GBM)

Posted: April 9, 2015

Vol. 4, Issue 3 : Oncologic Imaging – The Benefits of Diffusion Weighted MRI

Posted: April 3, 2015

Vol. 4, Issue 1 : Magnetic Resonance Elastography – Evaluation of Liver Disease

Posted: April 1, 2015

Intrinsic Imaging Obtains ISO 22301 Business Continuity Management System Certification

Posted: March 31, 2015

Intrinsic Imaging Awarded Phase II Clinical Trial for Treatment of Advanced Squamous Cell Carcinoma (SCC)

Posted: March 30, 2015

Intrinsic Imaging Appoints Ms. Amy Zastawney, RN MPH. as VP, Business Development

Posted: March 10, 2015

Intrinsic Imaging Awarded Interventional Medical Device Trial for Prevention of Pulmonary Emboli

Posted: March 3, 2015

Intrinsic Imaging Reports Exceptional 2014 Customer Satisfaction Survey Results

Posted: February 26, 2015

Vol. 4, Issue 11 : Osteoporosis Imaging

Posted: November 10, 2014

Vol. 4, Issue 10 : Echocardiography : Advantages in Clinical Trials

Posted: October 10, 2014

Vol. 4, Issue 9 : Muscular Dystrophy: Medical Imaging in Clinical Trials

Posted: September 9, 2014

Medical Imaging Consulting Group Expanded at Intrinsic Imaging

Posted: September 2, 2014

Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkins Lymphoma

Posted: August 29, 2014

Intrinsic Imaging Awarded International Phase II Study for Novel Vascular Medical Device

Posted: August 21, 2014

Intrinsic Imaging Awarded Genitourinary Medical Device Clinical Trial

Posted: August 12, 2014

Vol. 4, Issue 8 : The Advances of High Field MRI in the Assessment of Arthritis

Posted: August 8, 2014

Intrinsic Imaging ISO 13485 Medical Device Certification Leads to Award of Lung Cancer Clinical Trial

Posted: July 11, 2014

Vol. 4, Issue 7 : Computed Tomography Data Acquisition in Clinical Trials

Posted: July 7, 2014

Intrinsic Imaging Awarded Landmark Medical Device Trial for Treatment of Symptomatic Venous Outflow Obstruction

Posted: July 5, 2014

Vol. 4, Issue 6 : The Challenges of Reducing Lung Cancer Mortality with Screening

Posted: June 6, 2014

Vol. 4, Issue 5 : Orthopedic Device Assessments : Challenges in Clinical Trials

Posted: May 5, 2014

Intrinsic Imaging Awarded Global Clinical Trial for Hepatocellular Carcinomas

Posted: April 23, 2014

Vol. 4, Issue 4 : Imaging Analysis and Operative Treatment of Diaphyseal Fractures

Posted: April 4, 2014

Intrinsic Imaging Awarded Clinical Study for Novel Neurointerventional Medical Device

Posted: February 12, 2014

Vol. 4, Issue 2 : Screening Mammography CAD

Posted: February 9, 2014

Intrinsic Imaging Obtains ISO 13485 Medical Device Certification

Posted: September 24, 2013

Intrinsic Imaging Core Lab Expertise Contributes to Another FDA Approval

Posted: September 10, 2013

Intrinsic Imaging Awarded Phase II Clinical Trial for Cardiovascular Disease

Posted: September 5, 2013

Intrinsic Imaging Awarded Multi-Center Study for a Novel Vascular Medical Device

Posted: August 13, 2013

Intrinsic Imaging Awarded International Phase II Clinical Trial for Chronic Iron Overload

Posted: July 29, 2013

Metastatic Colorectal Cancer (mCRC) Phase I/II Trial Awarded to Intrinsic Imaging

Posted: July 15, 2013

Intrinsic Imaging Awarded Large 5 Year International Phase II Clinical Trial to Treat Iron Overload

Posted: March 13, 2013

Intrinsic Imaging Opens Medical Imaging Office in Greater Boston

Posted: February 26, 2013

Orthopedic Medical Device Phase III Clinical Trial Awarded to Intrinsic Imaging

Posted: September 18, 2012

Intrinsic Imaging Awarded Large International Phase III Clinical Trial for the Treatment of Severe Traumatic Brain Injury

Posted: August 22, 2012

Intrinsic Imaging Undergoes Extensive FDA Audit – Receives Zero 483 Observations

Posted: August 7, 2012

Intrinsic Imaging Awarded International Phase III Clinical Trial for Cystic Fibrosis

Posted: July 18, 2012

Intrinsic Imaging Awarded Phase II Trial for Metastatic Pancreatic Cancer

Posted: June 20, 2012

Intrinsic Imaging Core Lab Expertise Contributes to FDA Clearance of Medical Device

Posted: March 20, 2012

Intrinsic Imaging Implements ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems

Posted: March 6, 2012

Intrinsic Imaging Awarded Cardiovascular Clinical Trial

Posted: January 31, 2012

Intrinsic Imaging Awarded Important Clinical Trial for the Evaluation of Breast Disease

Posted: January 10, 2012

Neurointerventional Medical Device Clinical Trial Awarded to Intrinsic Imaging

Posted: September 29, 2011

Intrinsic Imaging Awarded Multinational Phase II Trial for the Study of Metastatic Breast Cancer

Posted: July 27, 2011

Metastatic Colorectal Cancer Clinical Trial Awarded to Intrinsic Imaging

Posted: May 25, 2011

Intrinsic Imaging Awarded Pivotal Multi-Center Clinical Trial for Acute Ischemic Stroke

Posted: May 16, 2011

Intrinsic Imaging Appoints Leading Vascular and Interventional Radiologist Dr. Amit Mehta as Vice President and Chief Medical Officer

Posted: December 16, 2010

Intrinsic Imaging Publishes Its Metrics Champion Consortium Imaging Performance Targets

Posted: September 29, 2010

Announcing Intrinsic Imaging – Radiology Experts Launch Novel Medical Imaging Core Lab for Clinical Trials

Posted: June 30, 2010